Disc Medicine, Inc.

Disc Medicine, Inc. (Nasdaq: FSDC) is a blank check company that completed its initial public offering in 2020 and filed its annual 10-K report with the SEC on March 29, 2021, covering fiscal year 2020. Structured as a special purpose acquisition company, FSDC was formed to pursue a merger, share exchange, asset acquisition, or similar business combination, with a stated focus on the healthcare and life sciences sector. As of the filing date, the company remained in its search phase, actively evaluating potential target businesses. For the complete filing history, sponsor details, deal timeline, and current status of FSDC, sign up for full data access on SpacDesk.